| Adaptor Proteins |
|
| Product Name |
Product # |
| FADD human |
F1302 |
| Antibodies to Death Receptor Ligands |
back to top |
| Product Name |
Product # |
| Anti-APRIL, Extracellular Domain 2 antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
A1851 |
| Anti-APRIL, Extracellular Domain antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
A1726 |
| Anti-BAFF antibody produced in rabbit ~0.5 mg/mL IgG fraction of antiserum Buffered aqueous solution |
B4805 |
| Anti-CD30 Ligand antibody produced in goat Affinity isolated antibody Lyophilized powder |
C5612 |
| Anti-CD40 Ligand antibody produced in goat Affinity isolated antibody Lyophilized powder |
C6487 |
| Monoclonal Anti-Fas Ligand antibody produced in mouse ~1 mg/mL Clone Alf2.1 Purified immunoglobulin Buffered aqueous solution |
F2051 |
| Monoclonal Anti-Fas Ligand antibody produced in mouse ~1 mg/mL Clone Alf1.2 Purified immunoglobulin Buffered aqueous solution |
F1926 |
| Monoclonal Anti-Fas Ligand antibody produced in rat Clone 101624 Purified immunoglobulin Lyophilized powder |
F2928 |
| Monoclonal Anti-TRAIL antibody produced in mouse Clone 75411.11 Purified immunoglobulin Lyophilized powder |
T3067 |
| Anti-TRAIL antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
T9191 |
| Apoptosis Inducers |
back to top |
| Product Name |
Product # |
| N-Acetyl-L-cysteine Sigma Grade ³99 % (TLC) powder |
A7250 |
| N-Acetyl-L-cysteine cell culture tested |
A9165 |
| N-Acetyl-D-sphingosine ~98 % (TLC) powder |
A7191 |
| Actinomycin D from Streptomyces sp. ~98 % (HPLC) |
A1410 |
| Actinomycin D from Streptomyces sp. powder ³95 % cell culture tested |
A9415 |
| Antimycin A from Streptomyces sp. |
A8674 |
| Adenosine 3',5'-cyclic monophosphate sodium salt monohydrate ~98 % (HPLC) powder |
A6885 |
| 17-(Allylamino)-17-demethoxygeldanamycin ³98 % (HPLC) solid |
A8476 |
| Anisomycin from Streptomyces griseolus ~97 % (TLC) solid |
A9789 |
| Arachidonic acid from porcine liver ~99 % (capillary GC) oil |
A9673 |
| Arachidonic acid sodium salt from porcine liver ~99 % (capillary GC) powder |
A8798 |
| Arachidonylethanolamide ~98 % (TLC) oil |
A0580 |
| Bafilomycin A1 from Streptomyces griseus ³90 % (HPLC) |
B1793 |
| Berberine chloride |
B3251 |
| Berberine hemisulfate ³95 % |
B3412 |
| BH3I-1 ³97 % (HPLC) powder, yellow |
B8809 |
| Bisbenzimide H 33342 ³95 % (TLC) |
B2261 |
| Bleomycin sulfate from Streptomyces verticillus crystalline 1.2-1.7 units/mg solid |
B5507 |
| Bleomycin sulfate from Streptomyces verticillus cell culture tested crystalline 1.2-1.7 units/mg solid |
B8416 |
| 4-Bromo-calcium Ionophore A23187 powder |
B7272 |
| Butein solid |
B-178 |
| Sodium butyrate ~99 % |
B5887 |
| Caffeic acid phenethyl ester >97 % (HPLC and TLC) powder |
C8221 |
| Calcimycin A23187 ³98 % (TLC) powder |
C7522 |
| Calcimycin A23187 hemicalcium salt powder |
C9275 |
| Calcimycin A23187 hemimagnesium salt |
C9400 |
| Calphostin C from Cladosporium cladosporioides ³90 % (HPLC) powder |
C6303 |
| (S)-(+)-Camptothecin ~95 % (HPLC) powder |
C9911 |
| Z-Leu-Leu-Leu-al ³80 % (HPLC) Solid film |
C2211 |
| Chelerythrine chloride ~95 % (TLC) powder |
C2932 |
| Colchicine ~95 % (HPLC) powder |
C9754 |
| Concanamycin A ³70 % (HPLC) |
C9705 |
| Corticosterone ³92 % |
C2505 |
| Cycloheximide microbial ³94 % (TLC) |
C7698 |
| Cycloheximide Ready Made Solution microbial 100 mg/mL in DMSO |
C4859 |
| Cyclophosphamide monohydrate |
C0768 |
| Cyclosporin A from Tolypocladium inflatum ³95 % (HPLC) solid |
C3662 |
| Daunorubicin hydrochloride USP |
D8809 |
| Demecolcine ³98 % (TLC) |
D7385 |
| Demecolcine solution liquid 10 µg/mL in HBSS |
D1925 |
| Dexamethasone ³98 % (HPLC) powder |
D1756 |
| Dexamethasone powder ³97 % cell culture tested |
D4902 |
| Dexamethasone powder cell culture tested |
D8893 |
| Dexamethasone-Water Soluble cell culture tested |
D2915 |
| Diethylenetriamine/nitric oxide adduct solid |
D-185 |
| 2,5-Dihydroxycinnamic acid methyl ester ³95 % crystalline |
D2667 |
| Doxorubicin hydrochloride ~98 % (TLC) |
D1515 |
| Emetine dihydrochloride hydrate |
E2375 |
| Etoposide synthetic ³98 % powder |
E1383 |
| 5-Fluorouracil ³99 % (TLC) powder |
F6627 |
| Forskolin Coleus forskohlii ³98 % (HPLC) powder |
F6886 |
| Fumonisin B1 from Fusarium moniliforme ~98 % (TLC) |
F1147 |
| Genistein synthetic ³98 % (HPLC) powder |
G6649 |
| Genistein from Glycine max (soybean) ~98 % (HPLC) |
G6776 |
| HA 14-1 ³94 % (HPLC) powder |
H8787 |
| Hexadecyl phosphocholine ~99 % (TLC) |
H6772 |
| N-Hexanoyl-D-sphingosine semisynthetic from bovine brain D-sphingosine ~98 % (TLC) |
H6524 |
| Homoharringtonine |
H0635 |
| 15(S)-Hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid ~100 µg/mL in ethanol ³95 % |
H9521 |
| 13(S)-Hydroperoxy-(9Z,11E)-octadecadienoic acid ~100 µg/mL in ethanol ³95 % |
H9271 |
| Retinoic acid p-hydroxyanilide |
H7779 |
| Hydroxyurea ³98 % (TLC) powder |
H8627 |
| Hypericin from Hypericum perforatum ³85 % (HPLC) powder |
H9252 |
| Ionomycin calcium salt Streptomyces conglobatus ³98 % (TLC) powder |
I0634 |
| H-7 dihydrochloride |
I7016 |
| H-89 |
B1427 |
| KN-93 |
K1385 |
| Lactacystin ³90 % (TLC) |
L6785 |
| b-Lapachone 98 % (TLC) |
L2037 |
| LY-294,002 hydrochloride solid |
L9908 |
| Methotrexate hydrate powder ³98 % (HPLC) cell culture tested insect cell culture tested |
M8407 |
| Microcystin LR from Microcystis aeruginosa ³95 % (HPLC) Solid film |
M2912 |
| Mitomycin C Streptomyces caespitosus |
M0503 |
| Nifedipine ³98 % (TLC) powder |
N7634 |
| S-Nitroso-N-acetylpenicillamine ³97 % |
N3398 |
| S-Nitrosoglutathione ³97 % |
N4148 |
| Okadaic acid from Prorocentrum concavum ³90 % (HPLC) Translucent film |
O4511 |
| Okadaic acid ammonium salt from Prorocentrum concavum ³90 % (HPLC) solid |
O8010 |
| Okadaic acid potassium salt from Prorocentrum concavum ³90 % (HPLC) powder |
O7885 |
| Okadaic acid sodium salt from Prorocentrum concavum ³90 % (HPLC) Film |
O7760 |
| Okadaic acid from Prorocentrum concavum ~95 % (HPLC) |
O9381 |
| Oligomycin Streptomyces diastatochromogenes ~65 % as oligomycin A (Composition given on label) ³90 % as total oligomycins (HPLC) |
O4876 |
| Paclitaxel from semisynthetic (from Taxus sp.) ³97 % |
T7191 |
| Paclitaxel from Taxus brevifolia ³95 % (HPLC) powder |
T7402 |
| Paclitaxel from Taxus yannanensis ³97 % (HPLC) powder |
T1912 |
| PETCM ³99 % (HPLC) solid |
P0871 |
| Phorbol 12-myristate 13-acetate ³99 % (TLC) Film or powder |
P8139 |
| Puromycin dihydrochloride from Streptomyces alboniger ³98 % (TLC) powder |
P7255 |
| Ammonium pyrrolidinedithiocarbamate ~99 % |
P8765 |
| Quercetin dihydrate ³98 % (HPLC) powder |
Q0125 |
| Rapamycin from Streptomyces hygroscopicus ³95 % (HPLC) powder |
R0395 |
| Spermine ~97 % |
S3256 |
| Spermine cell culture tested ³96 % Amorphous semi-solid |
S4264 |
| Spermine tetrahydrochloride ³95 % (TLC) |
S2876 |
| D-Sphingosine synthetic |
S7049 |
| Staurosporine Streptomyces sp. ³95 % (HPLC) solid |
S4400 |
| Streptonigrin from Streptomyces flocculus ³98 % |
S1014 |
| Sulindac Sulfide |
S3131 |
| Sulindac sulfone 99 % (TLC) solid |
S1438 |
| Tamoxifen ³99 % |
T5648 |
| Tamoxifen citrate salt ³99 % |
T9262 |
| N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine |
P4413 |
| 4-Hydroxytamoxifen ³98 % (TLC) powder |
H7904 |
| 4-Hydroxytamoxifen Minimum 70% of Z isomer (remainder primarily E-isomer) |
H6278 |
| Thapsigargin ³90 % (HPLC) Liquid or film |
T9033 |
| Triptolide from Tripterygium wilfordii ³98 % (HPLC) solid |
T3652 |
| Tyrphostin AG 490 solid |
T3434 |
| Valinomycin ³90 % (HPLC) solid |
V0627 |
| (±)-Verapamil hydrochloride ³99.0 % (titration) powder |
V4629 |
| Veratridine ³90 % (TLC) powder |
V5754 |
| Vinblastine sulfate salt ³97 % (TLC) powder |
V1377 |
| Apoptosis Inhibitors |
back to top |
| Product Name |
Product # |
| N-Acetyl-L-cysteine Sigma Grade ³99 % (TLC) powder |
A7250 |
| N-Acetyl-L-cysteine cell culture tested |
A9165 |
| Actinomycin D from Streptomyces sp. ~98 % (HPLC) |
A1410 |
| Actinomycin D from Streptomyces sp. powder ³95 % cell culture tested |
A9415 |
| Calpain Inhibitor II ³97 % (TLC) powder |
A6060 |
| Calpain Inhibitor I ³97 % (TLC) powder |
A6185 |
| 3-Aminobenzamide ³99 % (TLC) |
A0788 |
| Aphidicolin Nigrospora sphaerica ³98 % (GC) powder |
A0781 |
| Aurintricarboxylic acid practical grade ³85 % (titration) powder |
A1895 |
| Bongkrekic acid solution 1 mg/mL in 0.01 M Tris buffer, pH 7.5 ³95 % (HPLC) from Pseudomonas cocovenenans |
B6179 |
| Caffeine ReagentPlusä powder |
C0750 |
| Calcimycin A23187 ³98 % (TLC) powder |
C7522 |
| Calcimycin A23187 hemicalcium salt powder |
C9275 |
| Calcimycin A23187 hemimagnesium salt |
C9400 |
| Calyculin A from Discodermia calyx ~90 % (HPLC) solid |
C5552 |
| Cycloheximide microbial ³94 % (TLC) |
C7698 |
| Cyclosporin A from Tolypocladium inflatum ³95 % (HPLC) solid |
C3662 |
| 3,4-Dichloroisocoumarin |
D7910 |
| Diisopropyl fluorophosphate |
D0879 |
| Emetine dihydrochloride hydrate |
E2375 |
| N-Ethylmaleimide SigmaUltra |
E1271 |
| N-Ethylmaleimide crystalline ³98 % (HPLC) |
E3876 |
| Genistein synthetic ³98 % (HPLC) powder |
G6649 |
| Genistein from Glycine max (soybean) ~98 % (HPLC) |
G6776 |
| Guanosine 3',5'-cyclic monophosphate sodium salt ³98 % (HPLC) powder |
G6129 |
| Hemoglobin from bovine blood Lyophilized powder |
H2500 |
| Herbimycin A from Streptomyces hygroscopicus ³95 % (HPLC) powder |
H6649 |
| Insulin-like Growth Factor-I human ³97 % (SDS-PAGE or HPLC) recombinant, expressed in Escherichia coli Lyophilized powder cell culture tested |
I3769 |
| Interleukin-1b rat ³98 % (SDS-PAGE and HPLC) recombinant, expressed in Escherichia coli Lyophilized powder cell culture tested |
I2393 |
| Interleukin-1b human ³98 % (SDS-PAGE and HPLC) recombinant, expressed in Escherichia coli Lyophilized powder |
I9401 |
| Interleukin-1b from mouse ³98 % (SDS-PAGE and HPLC) recombinant, expressed in Escherichia coli Lyophilized powder cell culture tested |
I5271 |
| Interleukin-6 from mouse ³98 % (SDS-PAGE and HPLC) recombinant, expressed in Escherichia coli Lyophilized powder cell culture tested |
I9646 |
| Interleukin-6 human ³97 % (SDS-PAGE) recombinant, expressed in Escherichia coli Lyophilized powder cell culture tested |
I1395 |
| Leupeptin hydrochloride microbial ³70 % (HPLC) |
L0649 |
| Leupeptin hemisulfate salt microbial ³90 % (HPLC) |
L2884 |
| Leupeptin trifluoroacetate salt ³90 % (HPLC) microbial |
L2023 |
| MDL 28170 ³95 % (HPLC) |
M6690 |
| Pifithrin-a ³95 % (HPLC) powder |
P4359 |
| Cyclic Pifithrin-a >95 % (HPLC) |
P4236 |
| Phenylarsine oxide ³97 % powder |
P3075 |
| Phenylmethanesulfonyl fluoride >99 % (GC) |
P7626 |
| Phorbol 12,13-dibutyrate ³98 % (TLC) powder |
P1269 |
| Ammonium pyrrolidinedithiocarbamate ~99 % |
P8765 |
| SB 203580 powder |
S8307 |
| Spermine ~97 % |
S3256 |
| Spermine cell culture tested ³96 % Amorphous semi-solid |
S4264 |
| Spermine tetrahydrochloride ³95 % (TLC) |
S2876 |
| Superoxide Dismutase bovine erythrocytes Lyophilized powder 2,500-7,000 units/mg protein |
S2515 |
| Superoxide Dismutase bovine erythrocytes cell culture tested Lyophilized powder 2,500-7,000 units/mg protein |
S5395 |
| Superoxide Dismutase from human erythrocytes Lyophilized powder ³99 % ³1,350 units/mg protein |
S9636 |
| Na-p-Tosyl-L-lysine chloromethyl ketone hydrochloride ³97 % (TLC) powder |
T7254 |
| (±)-Verapamil hydrochloride ³99.0 % (titration) powder |
V4629 |
| Antibodies to Adaptors |
back to top |
| Product Name |
Product # |
| Anti-ASC/TMS1 antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
A1601 |
| Anti-Daxx antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
D7810 |
| Monoclonal Anti-FADD antibody produced in mouse ~2 mg/mL Clone FD19 Purified immunoglobulin Buffered aqueous solution |
F8053 |
| Anti-MADD antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
M5683 |
| Anti-MyD88, C-Terminal antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
M9934 |
| Anti-MyD88, Internal Domain antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
M0185 |
| Anti-RAIDD antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
R5275 |
| Anti-RAIDD, Internal Domain antibody produced in rabbit ~0.5 mg/mL IgG fraction of antiserum |
R9775 |
| Anti-RIP (Receptor Interacting Protein) antibody produced in rabbit Affinity isolated antibody Buffered aqueous solution |
R8274 |
| Anti-RIP3 antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
R4277 |
| Antibodies to DNA Fragmentation |
back to top |
| Product Name |
Product # |
| Anti-CAD antibody produced in rabbit Affinity isolated antibody Buffered aqueous solution |
C7852 |
| Anti-CIDE-A, C-Terminal antibody produced in rabbit Affinity isolated antibody Buffered aqueous solution |
C7977 |
| Anti-CIDE-A, C-Terminal antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
C7987 |
| Anti-CIDE-B, C-Terminal antibody produced in rabbit Affinity isolated antibody Buffered aqueous solution |
C8102 |
| Anti-Deoxyribonuclease I (DNase I) antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
D0188 |
| Anti-Deoxyribonuclease II (DNase II) antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody |
D1689 |
| Anti-Endonuclease G antibody produced in rabbit ~1 mg/mL Affinity isolated antibody Buffered aqueous solution |
E5654 |
| Monoclonal Anti-Excision Repair Cross Complementing Protein-1 antibody produced in mouse ~1 mg/mL Clone 8F1 Purified immunoglobulin Buffered aqueous solution |
E8903 |
| Anti-DFF45, C-Terminal antibody produced in rabbit Affinity isolated antibody Buffered aqueous solution |
I7653 |
| Anti-DFF45, C-Terminal antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
D3313 |
| Anti-DFF45, N-Terminal antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
D3438 |
| Anti-DFF45, N-Terminal antibody produced in rabbit Affinity isolated antibody Buffered aqueous solution |
I7528 |
| Monoclonal Anti-Thymine Dimer antibody produced in mouse ~2 mg/mL Clone H3 Purified immunoglobulin Buffered aqueous solution |
T1192 |
| Bcl-2 Family Proteins |
back to top |
| Product Name |
Product # |
| BAD from mouse ³70 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous glycerol solution |
B1682 |
| Bcl-2 human ³90 % (SDS-PAGE) recombinant, expressed in Escherichia coli (Maltose Binding Protein (MBP) fusion protein, C-terminal truncated) Buffered aqueous glycerol solution |
B1182 |
| Bcl-w (Minus C-Terminus) human >95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous glycerol solution |
B1059 |
| Bcl-xL (Minus C-Terminus) human ~95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous solution |
B0934 |
| Bcl-xL (Minus C-Terminus) mouse ³95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous solution |
B8056 |
| BID from mouse ³95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous solution |
B8306 |
| BID human ³95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous solution |
B8181 |
| BID, Caspase-8-cleaved from mouse ³95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous solution |
C4733 |
| BID, Caspase-8-cleaved human ³95 % (SDS-PAGE) recombinant, expressed in Escherichia coli Buffered aqueous solution |
C4608 |
| Suppressors of Apoptosis |
back to top |
| Product Name |
Product # |
| Livin β/ML-IAP human > 95 % SDS-PAGE, Escherichia coli, Buffered aqueous solution |
L1040 |
| XIAP human > 95 % SDS-PAGE, Escherichia coli, Buffered aqueous solution |
X3378 |
| Antibodies to Suppressors of Apoptosis |
back to top |
| Product Name |
Product # |
| Anti- FLIP, N-Terminal antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
F9800 |
| Anti-FLIPa, C-Terminal antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
F6550 |
| Anti-FLIPg/d, C-Terminal antibody produced in rabbit ~0.5 mg/mL Affinity isolated antibody Buffered aqueous solution |
F9925 |
| Anti-FLIPL C-Terminal antibody produced in rabbit ~0.5 mg/mL IgG fraction of antiserum Buffered aqueous solution |
F9675 |
| Anti-ILP-2 antibody produced in rabbit ~1 mg/mL Affinity isolated antibody Buffered aqueous solution |
I4782 |
| Anti-NAIP antibody produced in rabbit Affinity isolated antibody Lyophilized powder |
N6648 |
| Anti-Survivin antibody produced in rabbit IgG fraction of antiserum Buffered aqueous solution |
S8191 |
| Anti-XIAP antibody produced in rabbit Affinity isolated antibody Lyophilized powder |
X2503 |
| Death & Decoy Receptors |
back to top |
| Product Name |
Product # |
| CD30/Fc Chimera human >95 % (SDS-PAGE) recombinant, expressed in mouse NSO cells Lyophilized powder |
C5862 |
| DcR1/Fc Chimera human ³95 % (SDS-PAGE) recombinant, expressed in mouse NSO cells Lyophilized powder cell culture tested |
D9688 |
| DcR2/Fc Chimera human ³95 % (SDS-PAGE) recombinant, expressed in mouse NSO cells Lyophilized powder cell culture tested |
D9813 |
| DcR3/Fc Chimera human >90 % (SDS-PAGE) recombinant, expressed in Sf 21 cells Lyophilized powder |
D2441 |
| DR4/Fc Chimera human ³97 % (SDS-PAGE) recombinant, expressed in Sf 21 cells Lyophilized powder cell culture tested |
D9438 |
| DR5/Fc Chimera human ³95 % (SDS-PAGE) recombinant, expressed in mouse NSO cells Lyophilized powder cell culture tested |
D9563 |
| Fas/Fc Chimera human ³97 % (SDS-PAGE) recombinant, expressed in mouse NSO cells Lyophilized powder cell culture tested |
F8674 |
| Fas/Fc Chimera mouse ³97 % (SDS-PAGE) recombinant, expressed in Sf 21 cells Lyophilized powder cell culture tested |
F8799 |
| Fas Intracellular Domain human >90 % (SDS-PAGE) recombinant, expressed in Escherichia coli (N-terminal histidine tagged) Buffered aqueous solution |
F2053 |
| TRAIL Receptor 2/Fc Chimera from mouse >95 % (SDS-PAGE) recombinant, expressed in Sf 21 cells Lyophilized powder |
T5819 |
| Cyclins & Nuclear Proteins |
back to top |
| Product Name |
Product # |
| Cdc25A, active human ~30 % recombinant, expressed in E. coli Buffered aqueous glycerol solution ~42,000 units/mg protein |
C7484 |
| Cdc25B, active human ~30 % recombinant, expressed in E. coli Buffered aqueous glycerol solution ~3,000 units/mg |
C7609 |
| Cyclin-dependent Kinase 2 human |
C8864 |
| Cyclin-dependent Kinase 5 human |
C8739 |
| p13suc1-Agarose |
P3104 |
| PSTAIRE peptide ³95 % (HPLC) |
P4480 |
| Wee1, active from rat N-terminal GST-tagged solution |
W4387 |
| Cell Cycle Regulators |
back to top |
| Product Name |
Product # |
| Aphidicolin Nigrospora sphaerica ³98 % (GC) powder |
A0781 |
| Apigenin ~95 % (TLC) from parsley powder |
A3145 |
| (-)-Blebbistatin 398 % solid from synthetic |
B0560 |
| CGP-74514A hydrochloride |
C3353 |
| Compound 52 ³98 % powder |
C2604 |
| Daidzein ³98 % synthetic |
D7802 |
| Destruxin A from Metarhizium anisopliae ³90 % (HPLC) |
D4921 |
| DIF-3 399 % (HPLC) solid |
D0567 |
| p-Fluoro-L-phenylalanine |
F4646 |
| 5-Fluorouracil ³99 % (TLC) powder |
F6627 |
| Homoharringtonine |
H0635 |
| Indirubin-3'-oxime |
I0404 |
| N9-Isopropylolomoucine ³98 % (HPLC) |
I0763 |
| Kenpaullone ³99 % |
K3888 |
| L-Mimosine from Koa hoale seeds ³98 % |
M0253 |
| Mizoribine ³98 % (TLC) |
M3047 |
| Monastrol ³95 % (HPLC) |
M8515 |
| Netropsin dihydrochloride from Streptomyces netropsis ³98 % (TLC and HPLC) powder |
N9653 |
| Olomoucine ³98 % (HPLC) |
O0886 |
| [Ala92]-Peptide 6 |
P7967 |
| Purvalanol A ³98 % (HPLC) powder |
P4484 |
| Roscovitine ³98 % (TLC) |
R7772 |
| Se-(Methyl)selenocysteine hydrochloride ³95 % (TLC) |
M6680 |
| Sobuzoxane ³99 % (HPLC) solid |
S4692 |
| TCPOBOP ³98 % (HPLC) solid |
T1443 |
| Trichostatin A from Streptomyces sp. ³98 % (HPLC) |
T8552 |
| Verruculogen from Penicillium verruculosum ~95 % |
V7755 |
| WP631 methanesulfonate ³97 % (HPLC) solid |
W3763 |
| XK469 ³98 % (HPLC) solid |
X3628 |
| |
back to top |
